QY Research, Inc.

Global Vinyl Ester Based Resins Sales Market Will Reach 21 Million US$ by 2025

This report studies the global Vinblastinesulphate (CAS 143-67-9) market status and forecast, categorizes the global Vinblastinesulphate (CAS 143-67-9) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia Indi

 

City of Industry, CA -- (SBWIRE) -- 07/16/2018 -- This report studies the global Vinblastinesulphate (CAS 143-67-9) market status and forecast, categorizes the global Vinblastinesulphate (CAS 143-67-9) market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.

Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn't survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.

The global Vinblastinesulphate (CAS 143-67-9) market is valued at 19 million US$ in 2017 and will reach 21 million US$ by the end of 2025, growing at a CAGR of 1.1% during 2018-2025.

The major players covered in this report

Guangzhou Hanfang Pharmaceutical

Hainan Vinca Biological Medicine Technology

Guangzhou Person Pharmaceutical

Hainan Yueyang Biotechnology

Hubei Honch Pharmaceutical

Fine Chemicals Corporation

Hengtengfu Biological Products

Vinkem

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Saudi Arabia

Turkey

Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

>98% Vinblastinesulphate

97-98% Vinblastinesulphate

Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Lymphoma

Lung Cancer

Breast & Ovarian Cancer

Leukemia

Other

The study objectives of this report are:

To analyze and study the global Vinblastinesulphate (CAS 143-67-9) sales, value, status (2013-2017) and forecast (2018-2025);

To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.

Focuses on the key Vinblastinesulphate (CAS 143-67-9) players, to study the sales, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Vinblastinesulphate (CAS 143-67-9) are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Vinblastinesulphate (CAS 143-67-9) Manufacturers

Vinblastinesulphate (CAS 143-67-9) Distributors/Traders/Wholesalers

Vinblastinesulphate (CAS 143-67-9) Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Vinblastinesulphate (CAS 143-67-9) market, by end-use.

Detailed analysis and profiles of additional market players.

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/363375/global-vinblastinesulphate-cas-143-67-9-sales-market

About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.